SLP insider trading
NasdaqGS HealthcareSimulations Plus, Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.
About Simulations Plus, Inc.
Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. It operates through Software and Services segments. The company offers GastroPlus, which predicts absorption, biopharmaceutics, pharmacokinetics, and pharmacodynamics in humans and animals; and DDDPlus and MembranePlus simulation products. It also provides products based on mechanistic and mathematical models, such as DILIsym, NAFLDsym, ILDsym, IPFsym, RENAsym, MITOsym, OBESITYsym, and Thales products. In addition, the company offers Absorption, Distribution, Metabolism, Excretion, and Toxicity (ADMET) predictor for chemistry-based computer program that takes molecular structures as inputs and predicts their properties; and MedChem Designer, as well as MonolixSuite products for modeling and simulation that allows for population analyses, rapid clinical trial data analyses, and regulatory submissions. Further, it provides clinical-pharmacology-based consulting services, which includes population pharmacokinetic and pharmacodynamic modeling, exposure-response analyses, clinical trial simulations, data programming, and technical writing services in support of regulatory submissions; and early drug discovery services. Additionally, the company offers creative and insightful consulting services to support its quantitative systems pharmacology and other modeling systems. The company serves pharmaceutical, biotechnology, agrochemical, cosmetics, and food industry companies, as well as academic and regulatory agencies. Simulations Plus, Inc. was incorporated in 1996 and is headquartered in Research Triangle Park, North Carolina.
Company website: www.simulations-plus.com
SLP insider activity at a glance
FilingIQ has scored 500 insider transactions for SLP since Oct 1, 2015. The most recent filing in our index is dated May 11, 2026.
Across the full history, 1 open-market purchases
and 251 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
The average FilingIQ composite score on SLP insider trades is 56.1/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.
Other Healthcare tickers with recent insider activity
Frequently asked
- How many insider trades does FilingIQ track for SLP?
- FilingIQ tracks 500 Form 4 insider transactions for SLP (Simulations Plus, Inc.), covering filings from Oct 1, 2015 onwards. 10 of those were filed in the last 90 days.
- Are SLP insiders net buyers or net sellers?
- Across the full Form 4 history for SLP, 1 transactions (0%) were open-market purchases and 251 (50%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does SLP insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
- What sector is SLP in?
- Simulations Plus, Inc. (SLP) is classified in the Healthcare sector, specifically Health Information Services, with a current market capitalisation of $249.62M.
Methodology & sources
Every SLP insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.